Clinical Trial Update: Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s Disease [NA]

View source ↗

Summary

A clinical trial update exploring how dietary modifications affect outcomes of continuous LCIG infusion in advanced Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa-carbidopa intestinal gel (levodopa-carbidopa intestinal gel)

Snippet

Sponsor: Sheba Medical Center | Conditions: Parkinson Disease | NA | Status: UNKNOWN